Introduction to Recombinant Human IL16 Protein
Recombinant Human IL16 Protein, also known as interleukin-16, is a cytokine that plays a vital role in the immune system. It is a glycoprotein that is produced by activated CD8+ T cells and functions as a chemoattractant for various immune cells. In this article, we will explore the structure, activity, and applications of Recombinant Human IL16 Protein.
Structure of Recombinant Human IL16 Protein
Recombinant Human IL16 Protein is a 130 amino acid protein with a molecular weight of approximately 14 kDa. It is composed of four alpha-helices and two beta-sheets, which form a compact globular structure. The protein also contains two potential N-glycosylation sites, which can affect its biological activity.
The gene encoding Recombinant Human IL16 Protein is located on chromosome 15 in humans and is highly conserved among different species. The primary structure of the protein is similar to other cytokines, but it has a unique C-terminal domain that is responsible for its chemoattractant activity.
Activity of Recombinant Human IL16 Protein
Recombinant Human IL16 Protein is a potent chemoattractant for various immune cells, including CD4+ T cells, monocytes, macrophages, and dendritic cells. It also has the ability to stimulate the production of other cytokines, such as IL-2 and IL-8, by these cells.
The chemoattractant activity of Recombinant Human IL16 Protein is mediated by its binding to the CD4 receptor, which is present on the surface of immune cells. This binding triggers a signaling cascade that leads to the migration of immune cells towards the site of inflammation or infection.
In addition to its chemotactic properties, Recombinant Human IL16 Protein also has immunomodulatory effects. It can inhibit the proliferation of CD4+ T cells and induce apoptosis in these cells. This makes it a potential therapeutic target for diseases involving abnormal CD4+ T cell proliferation, such as autoimmune disorders and certain types of cancer.
Applications of Recombinant Human IL16 Protein
Due to its diverse activities, Recombinant Human IL16 Protein has several potential applications in both research and clinical settings. One of the main uses of this protein is in studying the immune response and inflammation. Its ability to attract and modulate the activity of immune cells makes it a valuable tool for understanding the mechanisms of various diseases.
Recombinant Human IL16 Protein has also been investigated as a potential therapeutic agent. In preclinical studies, it has shown promising results in treating inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis. It has also been studied as a potential anti-cancer agent, as it can inhibit the growth of certain types of cancer cells.
Furthermore, Recombinant Human IL16 Protein has been used in diagnostic assays to measure the levels of this cytokine in biological samples. Elevated levels of IL-16 have been associated with various inflammatory conditions, making it a potential biomarker for disease diagnosis and monitoring.
Conclusion
In summary, Recombinant Human IL16 Protein is a cytokine with diverse activities in the immune system. Its structure, activity, and potential applications make it a valuable tool for studying immune responses and developing therapeutic interventions for various diseases. With ongoing research, this protein may hold even more promise for future medical advancements.
There are no reviews yet.